Global

CN EN
  1. HOME
  2. ABOUT US
    About Laekna Core Management Team Board of Directors Milestones Scientific Advisory Board Core Investors Honors & Awards
  3. R&D
    R&D Therapeutic Areas Candidates Pipeline Clinical Trials
  4. PARTNERSHIPS
    Strategic Partners Business Development Holistic Approach BD Contact
  5. INVESTORS
    Corporate Governance Financial Results Announcements and Circulars IR Calendar Listing Documents
  6. NEWS
    Press Releases Media Coverage
  7. CAREERS
    Global Team Career Development Jobs My Laekna
  8. CONTACT US
    Contact Us Leave Message
  9. RSS Feeds
NEWS
PRESS CENTER

Scroll down to see more

Latest Articles
Media Coverage Press Releases
Search
  1. 2024-11-20
    Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity
    Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity
    More
    More
    More
  2. 2024-10-16
    Laekna Initiated SC Cohort in the Phase I SAD Study of LAE102 for The Treatment of Obesity
    More
  3. 2024-09-19
    Laekna Announces Robust Phase 1b data of LAE002 (afuresertib) for treatment of HR+/ HER2- Breast Cancer at ESMO Congress 2024
    More
  4. 2024-08-19
    Laekna (2105.HK) Announces Interim Results 2024
    More
  5. 2024-08-13
    Invitation | 2024 Interim Results Announcement
    More
  6. 2024-08-07
    Laekna Announces Significant Progress in a Triple-combination therapy (afuresertib plus Sintilimab plus nab-paclitaxel) in patients with specific solid tumors who were resistant to anti-PD-1/PD-L1 therapy and have been accepted for presentation at the 2024 Annual Global Meeting of IGCS
    More
  7. 2024-07-24
    Laekna Announces Significant Progress on Clinical Developments
    More
12349
Media contact
communication@laekna.com
RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
  1. Name*
  2. Email*
  3. Company
  4. Occupation

News

Positions

Follow us on Linkedin

  1. HOME
  2. ABOUT US
  3. R&D
  4. PARTNERSHIPS
  5. INVESTORS
  6. NEWS
  7. CAREERS
  8. CONTACT US

Copyright © Laekna Therapeutics, All Rights Reserved.  沪ICP备17047795号 Privacy Policy

Follow us on Linkedin

Follow us on Wechat